N5,10-methylenetetrahydrofolate reductase activity in autopsied brain parts of chronic schizophrenics and controls and in vitro tryptoline formation.
We and others have shown that in vitro tryptoline (tetrahydro-beta-carboline) formation accounts for the apparent-N-methylating activity of a brain enzymatic preparation using 5-methyltetrahydrofolic acid (5-MTHF) as a cofactor and tryptamines or catecholamines as substrates. This paper demonstrates that N5,10-methylenetetrahydrofolate reductase (methylene reductase) is responsible for this in vitro tryptoline formation with human brain enzymatic preparations. Others have described a folate-responsive psychosis which was associated with markedly reduced methylene reductase activity. Therefore, we also have examined this enzymatic activity in autopsied brains from chronic schizophrenics and controls. There were no statistically significant differences between activities for schizophrenics and controls in the six brain regions studied. Thus, although it is possible that some subgroup of schizophrenics may be characterized by abnormal methylene reductase activity, there does not appear to be a general association between the two.
D000818:Animals; D001921:Brain / Q000201:enzymology* / Q000473:pathology; D002243:Carbolines / Q000378:metabolism*; D002908:Chronic Disease; D006801:Humans; D007211:Indoles / Q000378:metabolism*; D008745:Methylation; D008754:Methylenetetrahydrofolate Dehydrogenase (NADP) / Q000378:metabolism*; D010088:Oxidoreductases / Q000378:metabolism*; D051381:Rats; D012559:Schizophrenia / Q000201:enzymology* / Q000473:pathology
D002243:Carbolines; D007211:Indoles; D010088:Oxidoreductases; D008754:Methylenetetrahydrofolate Dehydrogenase (NADP)